Automated multi-slice extracellular and patch-clamp experiments using the WinLTP data acquisition system with automated perfusion control  by Anderson, William W. et al.
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WinLTP  is  a data  acquisition  program  for studying  long-term  potentiation  (LTP)  and  other  aspects  of
synaptic  function.  Earlier  versions  of WinLTP  (J.  Neurosci.  Methods,  162:346–356,  2007)  provided  auto-
mated  electrical  stimulation  and  data  acquisition  capable  of  running  nearly  an entire  synaptic  plasticity
experiment,  with  the  primary  exception  that  perfusion  solutions  had  to be changed  manually.  This auto-
mated stimulation  and  acquisition  was done  by using  ‘Sweep’,  ‘Loop’  and  ‘Delay’  events  to build scripts
using  the  ‘Protocol  Builder’.  However,  this  did  not allow  automatic  changing  of many  solutions  while
running  multiple  slice  experiments,  or solution  changing  when  this  had  to  be performed  rapidly  and
with  accurate  timing  during  patch-clamp  experiments.  We  report  here  the  addition  of  automated  perfu-
sion control  to  WinLTP.  First,  perfusion  change  between  sweeps  is enabled  by adding  the ‘Perfuse’  event
to  Protocol  Builder  scripting  and  is  used  in  slice  experiments.  Second,  fast  perfusion  changes  during  as
well  as between  sweeps  is enabled  by  using  the  Perfuse  event  in  the  protocol  scripts  to  control  changes
between  sweeps,  and  also  by  changing  digital  or  analog  output  during  a  sweep  and  is used  for  single  cell
single-line  perfusion  patch-clamp  experiments.  The  addition  of stepper  control  of  tube placement  allows
dual-  or  triple-line  perfusion  patch-clamp  experiments  for up  to 48  solutions.  The  ability  to automate
perfusion  changes  and  fully  integrate  them  with  the  already  automated  stimulation  and  data  acquisi-
tion  goes  a long  way  toward  complete  automation  of  multi-slice  extracellularly  recorded  and  single  cell
patch-clamp  experiments.. Introduction
One of the goals of electrophysiological data acquisition
rogram developers is to increase the ease of running single
xperiments, and to increase the number of experiments that can
e run simultaneously. This includes when complex stimulation
nd perfusion changes have to be performed very quickly such
s during a patch-clamp experiment, and when relatively simple
timulation and perfusion changes have to be performed at similar
imes on multiple slice experiments where making the correct
anipulation can become very demanding.
WinLTP is a Windows data acquisition program designed to
nvestigate long-term potentiation (LTP), long-term depression
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(LTD) and other synaptic responses and has already been described
in Anderson and Collingridge (2007).  The capabilities required
for basic LTP and LTD experiments include alternating two-input
extracellular pathway stimulation, LTP induction by single train,
theta burst, and primed burst stimulation, and LTD induction by
low frequency stimulation. Central to WinLTP is the ‘Protocol
Builder’, which enables scripts to be written containing ‘Loop’
(with counter), ‘Delay’, and stimulation/acquisition ‘Sweep’ events
that, in turn, enable complex stimulation and data acquisition
experiments to be performed. Protocol ﬂow can be changed while
the experiment is running. Furthermore, WinLTP is multi-tasking
in that gap-free Axon Binary Files can be generated by the ‘Con-
tinuous Acquisition’ task, which can run simultaneously with the
sweep generating Protocol Builder task. WinLTP also provides
on-line measurement of slope, peak amplitude, population-spike
amplitude, average amplitude, area, rise time, decay time and
duration of synaptic waveforms, and cell input resistance and
Open access under CC BY license.patch electrode series resistance.
In Anderson and Collingridge (2007),  the Protocol Builder
scripts were continuous loops regularly producing single pulse
sweeps. Induction of synaptic plasticity by electrical stimulation
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as performed either by manually evoking single train sweeps
or LTP or repetitive single pulse sweeps for LTD, or by using a
Run’ event section that could produce more complex induction
timulation such as repetitive train sweeps separated by single
ulse sweeps to induce in vitro kindling.
In this paper we discuss sequential scripts where once a stable
aseline has been determined, one click of the mouse causes the
est of the stimulation for the whole experiment to run. Further-
ore, we have added a ‘Perfuse’ event to the Protocol Builder that
llows changes of perfusion solution between sweeps. The Perfuse
vent produces digital or analog output which controls perfusion
ontrollers which turn perfusion valves on and off. This change
n perfusion between sweeps can also be coupled by changes in
erfusion solution during sweeps.
Most electrophysiological data acquisition programs can pro-
uce perfusion changes during sweeps by changing digital or analog
utput during the sweeps, but changes between sweeps is usually
one manually. There are, to our knowledge, three other electro-
hysiological programs that can also produce perfusion changes
etween sweeps, Heka’s PatchMaster (www.heka.com), Molecu-
ar Device’s pClamp (www.moleculardevices.com), and Lohmann
esearch’s SynchroBrain (www.lohres.com).
WinLTP and its predecessor, the LTP Program (Anderson and
ollingridge, 2001), have been used in over 350 research papers. A
ree ‘Basic Mode’ version of WinLTP and a commercial ‘Advanced
ode’ version of WinLTP, with the Protocol Builder and automated
erfusion control, are available at www.winltp.com.
. Methods
WinLTP (version 2.00) is a Windows program that runs on Win-
ows XP, Vista and 7. It was written with Embarcadero (Borland)
++ Builder using Win32 VCL components. WinLTP uses National
nstruments M-  and X-Series boards and Molecular Devices Digi-
ata 1322A and 1320A boards. However, the automated perfusion
ontrol in WinLTP described here is currently only available on
he National Instruments boards. Other electrophysiological data
cquisition programs that use National Instruments boards include
xographX (www.axographx.com), GePulse, mPhys, Nclamp, Neu-
oRighter, QUB, Serf Software Electrophy, Slice, WinWCP, WinEDR,
nd custom in-house software using Igor (www.wavemetrics.com),
abView (www.ni.com), and MatLab (www.mathworks.com).
WinLTP is designed to control the 8 channel VC3-8 per-
usion controller from ALA Scientiﬁc (www.alascience.com),
he 8 channel ValveLink8.2 controller from Automate Sci-
ntiﬁc (www.autom8.com), the 8 channel VC-8P controller
rom Warner Instruments (www.warnerinstruments.com),
nd the 16 channel PC-16 controller from Bioscience Tools
www.biosciencetools.com).
All these controllers can be controlled by digital output (1
it/channel or valve, and more than one valve can be open at
nce—which is important for pre-ﬂush perfusion), or by analog
utput (usually 1 V/channel or valve for 8 channel controllers and
.5 V/channel or valve for 16 channel controllers, and only one valve
an be open at once). Most of the controllers can also be controlled
y 4-bit binary input to control 8, 15 or 16 channels with only one
alve open at a time.
In WinLTP, the two extracellular stimulating outputs (‘S0’ and
S1’) go to digital outputs 0 and 1 of the high-speed Port0 on M-  and
-Series boards and are used to trigger stimulus isolators. There are
n additional 4 sync outputs produced during a sweep that also go
o Port0, and these are used for Fast0 and Fast1 4-bit digital control
f 8, 15 or 16 channels on the perfusion controllers.
The M-  and X-Series boards also contain two static or ‘slow-
peed’ 8-bit digital output ports, Ports 1 and 2, and these are usednce Methods 207 (2012) 148– 160 149
for Slow0 and Slow1 8-bit digital control of one or two  perfusion
controllers. The 8-bit binary output from one port can control 4
pre-ﬂush channels (using 2 valves/channel), or 8 standard chan-
nels (1 valve/channel). The 16-bit binary output from both ports
together can control 8 pre-ﬂush channels or 16 standard channels.
These slow-speed ports are controlled in WinLTP by directly writ-
ing to them from within the program rather than having them being
written to by outputting a stream of data as is the case for the high-
speed Port0. Therefore, while timing for high-speed Port0 output is
accurate to the microsecond and is therefore suitable for accurately
changing outputs during as well as between sweeps, the timing for
slow-speed Ports 1 and 2 are usually accurate to milliseconds or
tens of milliseconds and are therefore only accurate enough for
perfusion changes between sweeps. Also, by using 1-bit per valve
rather than binary digital control, a single physical controller can,
in essence, be two  logical controllers. For example, Slow0 Port1 dig-
ital output can control 4 valves of an 8 valve controller, and Slow1
Port2 digital output can control the other 4 valves of the 8 valve
controller.
The intracellular analog stimulation output ‘IC0’ goes to Anal-
ogOut0 of the M-  and X-Series boards and usually controls the
command voltage of a patch-clamp ampliﬁer. The analog ‘IC1’ out-
put goes to AnalogOut1 and can control 8 or 16 channels and valves
on the perfusion controller. If an M-  or X-Series board is used that
has four analog outputs such as the PCIe-6323, AnalogOut2 can
control a second 8 channel perfusion controller while AnalogOut1
controls the ﬁrst 8 channel perfusion controller.
For slice experiments and fast perfusion changes during a sweep
by a stepper, the inexpensive, slowly operating pinch-valves, with
valve changing times of approximately 100 ms,  are appropriate. For
fast single-line perfusion changes, faster, more expensive valves,
such as Lee valves, with 4 ms  changing times, are required.
2.1. Consideration of N for multi-slice experiments
A major consideration when designing a multi-slice experiment
with automated perfusion control is: What will your N be? This will
determine the number of slices in a perfusion chamber, and if more
than one, whether the electrical stimulation of these slices will be
identical. Many researchers consider that an N of 1 is for 1 slice from
1 animal exposed to 1 experimental protocol (including both stim-
ulation and perfusion solutions). So if 1 slice each was obtained
from 2 animals, and these two  slices were exposed to the same
stimulation protocol and the same perfusion solutions, this would
be a ‘strict’ N of 2. And if 2 slices were obtained from 1 animal, and
these two  slices were exposed to the different stimulation protocols
and different perfusion solutions in different chambers, this would
also be a ‘strict’ N of 2. However, if 2 slices were obtained from 1
animal, and these two slices were exposed to the same stimulation
protocol and the same perfusion solutions, some researchers would
consider this to be an N of 2, and others would consider it a ‘strict’
N of 1. In general we do not favor exposing multiple slices obtained
from 1 animal to the same stimulation protocol and the same perfu-
sion solutions (which would equate to making a single biochemical
measurement in, say, triplicate and then averaging to obtain a single
N value). Similarly, when using expensive drugs or expensive trans-
genic animals, using more than 1 slice from the same animal and
exposing them to the same stimulation and perfusion protocol is
reasonable because it would increase the probability of a successful
experiment, however it would still be a ‘strict’ N of 1.
In general, WinLTP was  designed to provide, if necessary, com-
pletely different stimulation protocols and perfusion solutions for
one slice in one chamber. Four (and more) instances of WinLTP
can be run simultaneously on one computer, and each of these
WinLTPs can control completely separate stimulations and per-
fusions. And taking 4 slices from 1 animal and exposing them to
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Fig. 1. WinLTP layout for a basic LTP experiment showing the ‘Protocol Builder’ (upper left panel), ‘Analysis Graphs’ (in this case only one ‘Slope0’ graph, top right panel),
‘Sweep Acquisition’ (middle right panel), ‘Sweep Stimulation’ ﬁelds and graphs (lower left and right panels), and the ‘Spreadsheet’ and ‘Run’ buttons (bottom panels including
t ls are 
b s in th
r
d
c
t
3
b
0
d
e
r
‘
i
‘
I
c
o
L
‘
she  ‘Single T0’ Run Button). Detection ﬁelds to change analysis of synaptic potentia
utton  (lower black arrow), which evoked two ‘T0sweeps’ (marked by black arrow
ectangle in the Slope0 graph.
ifferent stimulations and perfusion solutions is clearly more difﬁ-
ult to do than taking 4 slices from 1 animal and exposing them to
he same stimulation and perfusion solution.
. Results
The basic capabilities of WinLTP have been described in detail
efore (Anderson and Collingridge, 2007). Since the WinLTP version
.94 of that paper, the following capabilities have been added (as
escribed in www.winltp.com):  the ‘RunOnce’ and ‘Run/ElseRun’
vents, graph zooming, ‘Maximum Slope’ measurement, series
esistance single or double exponential curve ﬁtting, a patch-clamp
SealTest Protocol’, analog train and ramp stimulation, convert-
ng WinLTP ASCII acquisition sweep ﬁles to Axon Binary ﬁles, an
Experimental Log’, and support for USB M-  and X-Series National
nstruments boards. In this paper we discuss automated perfusion
ontrol, protocol linking, and simultaneously running more than
ne WinLTP program on one computer.
Fig. 1 shows the layout of the WinLTP program to run a basic
TP experiment showing the ‘Protocol Builder’, ‘Analysis Graphs’,
Sweep Acquisition’ graphs, ‘Stimulation’ ﬁelds and graphs, ‘Spread-
heet’ and the ‘Run’ buttons. The Protocol Builder shows ‘P0sweeps’hidden. Two LTP induction trains were evoked by twice clicking the ‘Single T0’ Run
e Slope0 graph). The time of CaMKII Inhibitor application is shown by an imposed
repeating every 30 s, and each P0sweep produced only one S0 extra-
cellular stimulation pulse. The Sweep Acquisition graph shows a
ﬁeld EPSP evoked by S0 stimulation with the slope marked by a red
line. Slope calculations are shown by red diamonds in the ‘Slope0’
graph, and also in the ‘Spreadsheet’. Two LTP induction trains were
manually evoked by twice clicking the ‘Single T0’ Run button, which
produced two  100 S0 pulse T0sweeps (black arrows in the Slope0
graph). A CaM Kinase II Inhibitor was  applied before and during the
ﬁrst T0sweep train stimulation (indicated by the rectangle in the
Slope0 graph).
3.1. From circular to sequential scripting
The basic protocol construct in Fig. 1 is a circular script consisting
of a Loop event between the ‘MainProtocol’ and ‘EndProtocol’ lines:This Loop loops 99,999 times, which means looping continu-
ously for the duration of the experiment, and is therefore called
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 continuous loop. In circular scripting, a repeating P0sweep (or
lternating repetitive P0sweep/P1sweep) event is usually pro-
uced by putting a P0sweep (or a P0sweep/P1sweep) between
he Loop and ‘EndLoop’ event. This is used to provide baseline
timulation, and constant slow stimulation between induction
timulation and perfusion manipulations. When required, inter-
ittent induction stimulation is delivered by clicking on a ‘Single
weep’ Run button for LTP induction, or a ‘Repeat Sweep’ Run
utton for LTD induction. In Fig. 1, the two T0sweep trains
ere manually evoked by twice clicking on the ‘Single T0’ Run
utton.
In contrast, sequential scripts follow a linear, not circular, order
f events, and this is what experiments really are—a linear sequence
f events. While circular scripts are useful for initial investiga-
ions when you do not know exactly when you want to stimulate,
equential scripts are better once the timing of the delivery of the
timulation has been designed.
Fig. 2 shows the transformation from circular scripts to sequen-
ial scripts with automated perfusion by showing three different
rotocols that can produce stimulation similar to the LTP experi-
ent shown in Fig. 1. Fig. 2a is a circular script duplicating Fig. 1,
ith the two T0sweeps manually evoked by clicking on the ‘Sin-
le T0’ Run button (black arrows). The researcher has to be present
ach time to click the ‘Single T0’ sweep button.
Fig. 2b shows a circular script with a RunOnce event contain-
ng a single T0sweep. When the ‘Run’ checkbox is checked (red
rrows), the events in the RunOnce event are run once. In this case,
 single T0sweep will be run once each time the Run checkbox was
hecked. The RunOnce event also serves as an effective means of
ntermittently delivering complex induction stimulations (see Fig.
b,c in Anderson and Collingridge, 2007). The researcher still has
o be present each time to check the Run checkbox.
Fig. 2c shows how this protocol can be produced using a
equential script. At the start of the experiment just below the
ainProtocol line is the baseline loop section which contains a
ontinuous loop having one P0sweep, which in turn contains one
0 pulse. Because the checkbox of this Loop event is checked, it
tarts running once the ‘MainProtocol’ button is clicked, and one
0sweep and one S0 pulse is output in each loop. When this Loop
heckbox is unchecked (red arrow), this continuous loop is exited,
nd the next event in the Protocol Builder script is run—a single
0sweep to produce a train of S0 pulses. After this T0sweep, a non-
ontinuous set of 11 loops is run, each containing the P0sweep
to output 11 repetitive S0 pulses). Next the second T0 sweep
s run to produce a second S0 pulse train. And ﬁnally, after this
econd T0sweep, another non-continuous set of 8 loops is run
o ﬁnish up the experiment by outputting 8 more repetitive S0
ulses. With this protocol, the researcher only has to be present
o uncheck the continuous ‘Loop’ checkbox (when baseline sta-
ility has been achieved), and the rest of the stimulation outputs
utomatically.
.2. Sequential scripting with automated perfusion control
Although sequential scripting is useful when delivering auto-
ated electrical stimulation, its major strength becomes apparent
s when the automated delivery of electrical stimulation is cou-
led with the automated change of perfusion solutions. The usage
f sequential scripts coupled with automated perfusion control
llows almost completely automated experiments to be produced.
ig. 3 shows an example of this for a slice experiment—after achiev-
ng baseline stability, switching from Ch1 ACSF to a Ch2 CAMKII
nhibitor solution, delivering an LTP induction train in the CAMKII
nhibitor, switching back to the Ch1 ACSF wash, delivering a second
TP induction train in ACSF, and recording the ﬁnal responses. This
rotocol is analogous to the experiment in Fig. 1.nce Methods 207 (2012) 148– 160 151
Before starting the experiment, perfusion solution labels are
entered next to the perfusion channel number—‘ACSF’ is entered
next to Ch1, and ‘CaMKII Inhibitor’ next to Ch2 (Fig. 3a). This causes
the labels to appear beside the Perfuse event in the Protocol Builder
(Fig. 3b, left) and in the Experimental Log (Fig. 3c).
The perfusion solution can be manually changed when the
‘MainProtocol’ is not running by entering the channel number and
clicking on the ‘Apply’ button (Fig. 3a). Furthermore, if you wish to
run a MainProtocol with manual control of which perfusion chan-
nel is on, or you wish to override the automated perfusion control
while the MainProtocol is running, check the ‘Override’ checkbox
below the ‘Apply’ button. Alternatively, if you wish for the current
perfusion channel to remain on when the MainProtocol ﬁnishes,
check the ‘Set Ch to Last Perfuse’ checkbox.
At the start of the MainProtocol, the immediate ﬁrst ‘Slow0 Per-
fuse’ event makes sure that the experiment starts out perfusing the
channel 1 (‘ACSF’) solution. Then the protocol enters a continuous
loop with a P0sweep which produces the baseline stimulation. As
with the sequential scripting without automated perfusion control
(Fig. 2c), when the experimenter has decided that a stable base-
line has been reached, this baseline loop is exiting by unchecking
the Loop event (red arrow in Fig. 3b). The rest of the stimula-
tion/perfusion change sequence then runs without further manual
input.
The ﬁrst event after the baseline loop is exited is a Slow0 Perfuse
event, which changes the perfusion to channel 2 and begins perfus-
ing the CAMKII Inhibitor solution. This is indicated by the bottom
trace recording of Bit1 Port1, which shows switching from ‘Ch1’ to
‘Ch2’. Then a second loop containing a P0sweep is run for 8 times,
and is followed by the ﬁrst T0sweep LTP induction stimulation is
produced (shown by the ﬁrst train in the ‘AD0’ recording). Then a
third loop containing a P0sweep is run for 3 times, and the Slow Per-
fuse event changes the perfusion solution back to Ch1 ACSF (shown
in the ‘AD1’ recording). Then a fourth loop containing a P0sweep
is run for 8 times, followed by the second T0sweep LTP induction
stimulation (shown by the second train in the AD0 recording). After
this a post induction ﬁfth loop with a P0sweep is run 8 times, and
then the MainProtocol ends. The Experimental Log output when
this protocol is run (Fig. 3c) clearly shows the Slow0 Perfuse event
along with the time, perfusion channel number, either an ‘ACSF’
or ‘CaMKII Inhibitor’ perfusion solution label, and then next sweep
following the perfusion change.
3.3. Standard and pre-ﬂush automated perfusion of slices
WinLTP can control up to four perfusion lines. Slow0 and Slow1
perfusion change can each control one perfusion line by making
only ‘slow’ changes between sweeps. However, Fast0 and Fast1
perfusion change can each control one perfusion line by making
‘fast’ changes during sweeps as well as between sweeps. Normally
WinLTP uses Slow0 Perfusion Change for controlling one perfu-
sion line to one slice chamber, and that is what will be used here.
However, up to four perfusion line controls (Slow0, Slow1, Fast0
and Fast1) could be simultaneously used for multi-slice experi-
ments.
Mammalian single cell studies in culture typically use HEPES or
similar buffer which does not require bubbling with 95% O2 and
5% CO2. In contrast, mammalian brain slice experiments normally
use a bicarbonate buffer bubbled with 95% O2 and 5% CO2 for cor-
rect pH and maintained at 30–37 ◦C. For slice experiments, when
oxygenated/carboxygenated solution has stayed in polyethylene or
tygon tubing for a ‘long’ period of time before being perfused on the
slice, oxygen can diffuse across the tubing wall. This loss of oxygen
also causes changes in solution pH. Delivery of this stale solution
during solution changes is one of the main problems of automated
perfusion control in slice experiments.
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Fig. 2. From circular to sequential scripting. This protocol shows a series of non-averaging ‘P0sweeps’ (containing a single S0 pulse, recorded in AD0) separated by two
T0sweeps (containing an LTP induction train of 100 S0 pulses). (a) A circular script with a continuous loop of 99,999 loops analogous to Fig. 1. Two single T0sweeps are evoked
by  twice clicking the ‘Single T0’ sweep Run button (black arrows). (b) A circular script with a ‘RunOnce’ event containing a single T0sweep, where two T0sweeps are evoked
by  twice checking the ‘Run’ checkbox (red arrows). (c) A sequential script where, after a steady baseline has been determined, the entire stimulation sequence is started by
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The standard perfusion system involves 1 valve per perfusion
ine, and only one valve is open at a time (Fig. 4a1). The perfusion
ine1/Ch1 valve is open and oxygenated/carboxygenated solution
s ﬂowing through the manifold and into the chamber. The solution
n perfusion line2/Ch2 is not moving and the stale solution is not
eing bubbled with O2/CO2 and the pH is incorrect (indicated by
he red solution) because of the bicarbonate buffer. When the solu-
ion is switched to perfusion line1 to perfusion line2, the Ch1 valve
loses and at the same time the Ch2 valve opens. To do this WinLTP
hanges Port1 Bit0 from on to off and simultaneously changes Bit1
rom off to on (Fig. 5a). All the stale solution in perfusion line2 from
he reservoir to the manifold begins ﬂowing into the manifold, and
he chamber receives a big bolus of stale solution with incorrect
evels of O2, CO2 and pH.
Obviously, the smaller the volume of solution that ‘sits’ in the
erfusion line before being perfused onto the slice, the less effect
he stale solution will have on the slice. For slice experiments
sing standard perfusion, perfusion solution between the oxy-
enated/carboxygenated reservoir and the manifold (shown in red
n Fig. 4a1) is the crucial dead volume solution.
One way to reduce this dead volume in the standard perfusion
ystem is by mounting the syringe reservoir directly on top of theearcher having to be present. (For interpretation of the references to color in this
pinch valve, as is possible with some perfusion systems. This makes
the perfusion line from the reservoir to the pinch-valve negligible.
However, unless you are perfusing room temperature solution, the
solution has to be directly warmed by a heater directly surrounding
the reservoir syringe. Note also that there is still a short length
of tubing between the pinch valve and the manifold that is not
oxygenated/carboxygenated.
A second way  to reduce the amount of stale solution is for
WinLTP to pre-ﬂush the perfusion line between the oxygenated
reservoir and just above the valve to the chamber (Fig. 4a2). This
is done by inserting a ‘T’ junction just above this valve and hav-
ing a second waste line go through a ﬂush valve and on to a
waste container. The AutoPrime system from Automate Scientiﬁc
performs this type of pre-ﬂush. In Fig. 4a2 the chamber valve
for perfusion line1/Ch1 is open and the ﬂush valve to waste is
closed, and oxygenated/carboxygenated solution is ﬂowing into
the manifold and on into the chamber. When the solution perfus-
ing the chamber is about to be switched to perfusion line2, the
ﬂush valve for perfusion line2 ﬁrst opens to completely ﬂush the
line between the oxygenated/carboxygenated reservoir and the ‘T’
junction, and this solution goes into the waste bottle. Then simul-
taneously, the chamber valve for perfusion line1/Ch1 closes the
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Fig. 3. Sequential protocol script with automated perfusion control for a slice experiment. (a) Manual control of the perfusion channels panel (top). Enter the perfusion
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tolution label next to the perfusion channel number (bottom). (b) A sequential scr
timulation sequence is started by unchecking the Loop checkbox (red arrow), and t
s  run. (For interpretation of the references to color in this ﬁgure legend, the reader
ush valve for perfusion line2 closes, and the chamber valve for
erfusion line2/Ch2 opens. This causes the small bolus of stale
olution in perfusion line2 between the ‘T’ junction and the man-
fold to go into the manifold and on to the chamber, and this is
ollowed by oxygenated/carboxygenated solution. Thus, in a 4 per-
usion line pre-ﬂush system (Figs. 4a2 and 5b),  the pre-ﬂush of
ine2 is started by changing Port1 Bit5 from off to on, then once
ine2 is ﬂushed, simultaneously changing Bit5 to off to turn off
he ﬂush valve of perfusion line2/Ch2, changing Port1 Bit1 to on
o turn on the chamber valve of perfusion line2/Ch2, and chang-
ng Port1 Bit0 to off to turn off the chamber valve of perfusion
ine1/Ch1.
Pre-ﬂushing the perfusion line above the chamber valve can sub-
tantially reduce the bolus of stale solution entering the chamber,
ut does not eliminate it. The main drawback to this system is that
wo valves per perfusion line are required.
A third way to reduce the amount of unoxygenated solution
s to use a continuous-ﬂow-to-waste system (Fig. 4a3). With sys-
ems that use three-way ‘Normally Closed’–‘Normally Open’ pinch
alves, the perfusion line between the reservoir and the manifold
s placed in the Normally Closed slot of the pinch valve. A ‘Y’ junc-
ion is placed above the pinch valve, and a second perfusion line
s connected between this ‘Y’ junction, through the Normally Open
lot of the pinch valve and on to a waste container.
When the perfusion channel is off, the pinch valve controlling
he solution ﬂow between the ‘Y’ junction and the manifoldcluding Perfuse events to change perfusion solutions between sweeps. The entire
earcher can leave at this time. (c) The ‘Experimental Log’ output when this protocol
rred to the web version of this article.)
is Normally Closed and between the ‘Y’ junction and waste is
Normally Open, and the tubing between the reservoir and the ‘Y’
junction is ﬁlled with oxygenated/carboxygenated solution. When
the perfusion channel is turned on, the continuous-ﬂow-to-waste
stops, and oxygenated solution now ﬂows from the ‘Y’ junction to
the manifold. The dead volume with stale solution here is from the
‘Y’ junction to the manifold, and is indicated in red. The advantage
of the continuous-to-waste system is that only one valve per
perfusion line is required, the disadvantage is that expensive drug
solutions would be wasted.
Estimates of dead volume for 1.32′′ (0.8 mm)  inner diameter
tubing for the pre-ﬂush and continuous-ﬂow-to-waste systems
(between the ‘T’ or ‘Y’ junction above the chamber valve to the
manifold) are 0.05 ml  for 9 cm of tubing in a 4 channel system, and
0.08 ml  for 16 cm of tubing in an 8-channel system. The 1/32′′ tub-
ing volume (0.05–0.08 ml)  is probably negligible for a larger 1 ml
chamber, but could be too large for a 0.3 ml chamber.
In addition to these ways of reducing stale solution, other tech-
niques could include: (1) keep the dead volume as small as possible
by using as small a diameter tubing and as short a length of tubing
as possible between the junction and the manifold, (2) increase the
bath volume so that the dead volume is a smaller proportion of the
bath volume, (3) increase the ﬂow rate, and (4) use Teﬂon tubing
where the dead volume occurs, and possibly throughout your sys-
tem. Teﬂon tubing is less permeable to oxygen diffusing across the
tubing wall than polyethylene or tygon tubing.
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Fig. 4. Standard, pre-ﬂush and continuous-ﬂow-to-waste slice perfusion systems (a) and standard single cell single-line perfusion system (b). (a1) The slice standard perfusion
system with 1 valve/line. (a2) The slice pre-ﬂush perfusion system with 2 valves/line for a four-line perfusion system. The ﬂush valve has been turned on for a sufﬁcient
time  to clear the perfusion line from the reservoir to the T-junction, but the valve to the chamber has not yet been turned on. (a3) A continuous-ﬂow-to-waste perfusion
system using a Normally Open (‘NO’)–Normally Closed (‘NC’) pinch-valve to ﬂush the tubing between the reservoir and the ‘Y’ junction. The dead volume stale solution in the
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merfusion lines for these three systems is indicated in red. (b) The standard single-
ere  is from the manifold to the tip of the perfusion pipette (shown in dark purple)
o  the web version of this article.)
.4. Automated single-line perfusion patch-camp experiments
In the previous section we have discussed changing perfu-
ion solutions between sweeps during extracellularly recorded
ulti-slice experiments, and using pre-ﬂush and other tech-
iques to reduce the amount of stale, unoxygenated solution
elivered to the slice during solution changes. However, auto-
ated perfusion of single cell patch-clamp recording and has aerfusion system for single cell patch-clamp experiments. The crucial dead volume
interpretation of the references to color in this ﬁgure legend, the reader is referred
different set of problems. First, single cell patch-clamp experi-
ments use a HEPES or similar type buffer rather than a 95% O2/5%
CO2 bicarbonate buffer, so there is not the concern about stale,
unoxygenated altered pH solution in the lines. The dead volume
between the reservoir and the manifold is not a crucial concern,
and pre-ﬂushing the perfusion lines is not necessary. However,
in these experiments, perfusion solutions have to be changed
very quickly—sometimes within a millisecond, and so automated
W.W.  Anderson et al. / Journal of Neuroscience Methods 207 (2012) 148– 160 155
F Ch1 to
(  turns
p
a
a
m
t
t
m
a
s
l
i
I
s
p
t
a
t
d
o
c
a
b
c
d
o
a
h
wig. 5. Program output to an automated perfusion controller when switching from 
b)  a pre-ﬂush 4-channel conﬁguration. Note how the Ch2 Flush Valve (Port1, Bit5)
erfusion has to be able to be quickly changed both during as well
s between sweeps.
In this and the following sections we discuss two methods of
utomated perfusion control of single cell patch-clamp experi-
ents. The ﬁrst method is using a single-line perfusion between
he manifold and the end of the pipette near the cell, and solu-
ion application lasting 10s of milliseconds to seconds. The second
ethod is to use a stepper to move two or three perfusion tubes,
nd solution applications can be as short as 1 ms.
The single-line perfusion system is designed to work with the
tandard, not a pre-ﬂush, perfusion system where 4–16 perfusion
ines go into a manifold which then goes into a pipette of approx-
mately 100 m internal diameter and then onto the cell (Fig. 4b).
n these experiments, the biggest problem is the speed of the high-
peed valves and dead volume from the manifold to the end of the
ipette in the chamber (shown in dark purple in Fig. 4b), because
his affects how quickly new perfusion solutions can be changed
nd reach the cell.
Changing perfusion solutions between sweeps is controlled by
he Perfuse event in the Protocol Builder, and fast perfusion change
uring the sweep is controlled by changing either digital or analog
utput during the sweep.
For setting up a typical antagonist/agonist single line patch-
lamp experiment, a major question is whether or not the
ntagonist rapidly unbinds. This has a large effect on the num-
er of perfusion solutions (and valves) needed to get a good
oncentration–response curve. If the antagonist remains bound
uring the application of an agonist solution, then the antag-
nist does not need to be added to the agonist solution to get
n accurate concentration–response curve. Therefore, you can
ave separate solutions (and valves) for each agonist solution as
ell as each antagonist solution. For example, one eight-valve Ch2 in a slice experiment when using (a) a standard 8-channel conﬁguration, and
 on before the switch from Ch1 to Ch2 and then turns off at the switchover.
controller is sufﬁcient to do a concentration–response curve
for 4 agonist concentrations and 4 antagonist concentrations
(one of which could be no antagonist, i.e. ACSF). However, if the
antagonist does not remain bound during the application of the
agonist-only solution, then the antagonist has to be added to the
agonist solution to get an accurate concentration–response curve.
Therefore, many more agonist + antagonist solutions (and valves)
are required to do a concentration–response curve. For example,
to do a concentration–response curve for 4 agonists and only 3
antagonists requires 15 solutions, 15 valves, and one 16 or two  8
channel controllers.
Single-line perfusion can use AnalogOut1 or 4 bits on the high-
speed Port0 to control one 8 channel or one 16 channel controller, or
it can use two  analog outputs (AnalogOut1 + AnalogOut2) to control
two 8 channel controllers.
An example of single-line fast perfusion changes during and
between sweeps is shown in Fig. 6. This is for controlling an 8 chan-
nel perfusion controller using AnalogOut1 and to for applying 4
different agonists and 4 different antagonists when the antagonist
does not rapidly unbind. The four different agonist concentrations
are applied during the four different sweeps. The protocol in the
Protocol Builder (left panel) starts with the ‘Fast0 Perfuse’ event
causing ‘Antagonist 1’ to be perfused via channel 1. After a delay,
‘Agonist 1’ is applied via channel 5 for 1 s during the P0sweep.
Then shortly thereafter ‘Agonist 2’ (channel 6) is applied during
a P1sweep, ‘Agonist 3’ (channel 7) is applied during a T0sweep,
and ‘Agonist 4’ (channel 8) is applied during a T1sweep. Then
the perfusion solution is changed to ‘Antagonist 2’ (channel 2),
and application of the 4 agonist solutions is repeated, and this is
repeated for ‘Antagonist 3’ perfusion (via channel 3), and ﬁnally for
‘Antagonist 4’ perfusion (via channel 4). During the ﬁrst and third
epochs, ‘Step0’ and ‘Step2’, a −1 in the ‘Amplitude (V)’ ﬁeld (red
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Fig. 6. Single cell, single-line fast perfusion changes during and between sweeps—applying 4 different agonists and 4 different antagonists when the antagonist does not
rapidly  unbind. The ‘Fast0 Perfuse’ events (shown in red in the ‘Protocol Builder’ panel on the left) set the on-going perfusion to Ch1 Antag1, Ch2 Antag2, Ch3 Antag3 and
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ectangles) causes the current perfusion solution set by the Fast0
erfuse event in the Protocol Builder to be maintained in that part
f the sweep. During the ‘Step1’ epoch, a voltage from 1 to 8 in
he Amplitude (V) ﬁeld (black rectangle) changes the perfusion to
hannels 1–8.
Note that if your antagonist does not rapidly unbind, and there-
ore agonist solutions need not contain antagonist, it is strongly
referable to use AnalogOut1 rather than digital output for fast
erfusion changes during a sweep. This is because if you enter a
1 V into the Amplitude (V) ﬁeld of the epoch, that means that the
urrent fast perfusion channel will continue to be output during
weep epochs containing a −1 V, and therefore each sweep can con-
ain a unique agonist concentration, thereby limiting the number
f different sweep stimulations required.
.5. Using protocol linking to extend single-line perfusion
WinLTP currently can output four different sweep stimulations
P0, P1, T0 and T1) from one protocol ﬁle. When the antagonist
s tightly bound, this means you could deliver 4 agonist concen-
rations and up to 12 different antagonist concentrations (for up
o 16 channels) in one protocol ﬁle (when using −1 V and ana-
og output). However, when the antagonist is loosely bound and
he agonist solutions must also contain an antagonist, you couldweeps. During the ‘Step1’ epoch in the T1sweep (bottom panels), a voltage of 8 in
 interpretation of the references to color in this ﬁgure legend, the reader is referred
deliver only 1 antagonist concentration and 4 agonist concentra-
tions (with that one antagonist concentration) in one protocol ﬁle.
To test 3 antagonist concentrations and 4 agonist concentrations
(or 15 different solutions, 3 antagonist plus 12 agonist + antagonist
solutions), you would need to use ‘Protocol Linking’ to link 3 proto-
col ﬁles together. Patch-clamp automated single-line perfusion can
realistically involve delivering 15 different perfusion solutions, and
16 channels is a reasonable number of channels going into one man-
ifold. With Protocol Linking, once a protocol has ﬁnished, WinLTP
can now load and start a second protocol containing 4 different
solution changes, and then load and start a third protocol contain-
ing 4 further different solution changes, and WinLTP can do this,
ad inﬁnitum. The limitation is in the number of perfusion channels
available.
Fig. 7 shows a single-line perfusion experiment involving 3
antagonist concentration solutions and 4 agonist concentrations
(or 12 agonist + antagonist solutions), where the antagonist is
loosely bound to the receptor and has to be added to the agonist
solution during agonist application. The ‘Protocol Linking’ tab sheet
of the ﬁrst protocol ﬁle (FastPerfusion1.pro) is set to load the next
protocol ﬁle (FastPerfsuion2.pro) when the FastPerfusion1.pro
MainProtocol has self-terminated. Also, because the AutoStart
checkbox is checked, the second protocol ﬁle automatically
starts (Fig. 7a). So once the FastProtocol1.pro protocol runs and
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Fig. 7. Single cell, single-line perfusion with Protocol Linking. Protocol Linking is used to link 3 different protocol ﬁles to continuously perfuse 3 different antagonist
concentration solutions, and momentarily apply 4 different agonist concentration solutions also containing the antagonist. A total of 15 different solutions were applied. (a)
The  ‘Protocol Linking’ tab sheet of FastPerfusion1.pro protocol ﬁle which is set to load the next protocol ﬁle (FastPerfusion2.pro). Because the ‘AutoStart’ checkbox is checked,
FastPerfusion2.pro will automatically start. (b) A screenshot after the third linked protocol ﬁle has run. The ‘Analysis Graphs’ records the ‘DC baseline’ voltage of the initial
a les. (
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hntagonist voltage and the agonist + antagonist voltage for all three linked protocol ﬁ
nly  the ﬁrst sweep in a loop is set to be printed to the Log.
elf-terminates, FastProtocol2.pro loads, auto starts, runs and
elf-terminates, and then FastProtocol3.pro protocol loads, auto
tarts, runs and self-terminates, and the experiment is then ended
Fig. 7b).
Fig. 7b shows the results after the third linked protocol ﬁle
as ﬁnished. The ﬁrst protocol ﬁle (FastProtocol1.pro) deliveredc) The ﬁrst part of the ‘Experimental Log’ when the three linked protocols were run.
‘Antagonist 1’, then ‘Antagonist 1 + Agonist 1’, then ‘Antagonist
1 + Agonist 2’, then ‘Antagonist 1 + Agonist 3’, then ‘Antagonist
1 + Agonist 4’. The second protocol ﬁle (FastProtocol2.pro) deliv-
ered ‘Antagonist 2’, then ‘Antagonist 2 + Agonists 1 to 4’, and then
the third protocol ﬁle (FastProtocol3.pro) delivered ‘Antagonist 3’,
then ‘Antagonist 3 + Agonists 1 to 4’.
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Fig. 8. WinLTP control of triple-line perfusion using a Stepper. (a) Slow0, Slow1 and Fast1 Perfusion control three valve controllers, and the Fast0 Perfusion controls the
stepper  which controls whether the solution from Tube0 (blue), Tube1 (brown) or Tube2 (fuchsia) bathes the cell. The Fast0 Stepper therefore controls whether antagonist
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f  the references to color in this ﬁgure legend, the reader is referred to the web ver
The Protocol Builder (large panel on left) shows that when the
hird protocol ﬁle auto-starts, the Perfuse event causes ‘Antago-
ist 3’ solution to be continuously perfused (via channel 3). Then
our different sweeps (P0, P1, T0 then T1) are output 3 times.
ach sweep contains a 1000 ms  output of ‘Antagonist 3 + Agonist
’ (P0sweep, channel 12), ‘Antagonist 3 + Agonist 2’ (P1sweep,
hannel 13), ‘Antagonist 3 + Agonist 3’ (T0sweep, channel 14) and
Antagonist 3 + Agonist 4’ (T1sweep, channel 15, shown in the bot-
om two panels). For the T1sweep, setting the Step1 Amplitude
V) to 15 V turns on channel 15 perfusion (bottom left panel, black
ectangle). The top right Analysis Graphs panel shows DC output
oltages for turning on the channels 1–3 antagonist solutions and
hannels 4–15 antagonist + agonist solutions for the ﬁrst, linked
econd, and linked third protocol ﬁles. The ‘Continuous Acquisition’
anel shows the output voltage for the third protocol ﬁle only. In
his way, 1 antagonist solution and 4 agonist concentrations plus
he antagonist for each protocol ﬁle, or 3 antagonist solutions and
2 agonist + antagonist solutions, or a total of 15 solutions were
ested in the experiment.
The Experimental Log for these linked protocols (Fig. 7c) shows
tarting the ﬁrst protocol (FastPerfusion1.pro) with ‘Antag1’—up to
he loading and starting of the second protocol (FastPerfusion2.pro)
nd the switching to ‘Antag2’.
.6. Automated dual- and triple-line/stepper perfusion
atch-clamp experiments
Slice automated perfusion control is used to produce solu-
ion changes in the minutes timeframe. Single-line automated
erfusion control for patch-clamp experiments is used to pro-
uce solution applications in the tens of milliseconds to seconds
imeframe. In this section we implement perfusion applica-
ions as short as a millisecond in duration by using a stepper
long with two  or three valve controllers. In contrast to single-
ine perfusion, which requires using fast, expensive valves, the
ual- and triple-Line/stepper perfusion system needs to use onlye color coded Slow0, Slow1, Fast0, and Fast1 perfusion channels. (For interpretation
f this article.)
the slower, inexpensive pinch valves used with slice perfu-
sion.
WinLTP’s control of a triple-line/stepper perfusion system is
shown in Fig. 8. Slow0 and Fast1 perfusion each controls one perfu-
sion controller, each of which in turn usually controls 4–16 valves.
Slow0 and Fast1 usually output agonist or agonist + antagonist
solutions from Tube0 and Tube2, respectively. The Slow1 perfu-
sion controls another perfusion controller which in turn controls
4–16 valves. Slow1 usually outputs antagonist only solutions from
Tube1. The Slow0, Slow1 and Fast1 perfusion changes solutions
between sweeps. The Fast0 perfusion controls the stepper which
quickly moves the antagonist only Tube1 to either agonist (+antag-
onist) Tube0 or Tube2 during the sweep. If the stepper is a fast piezo
device, solution applications from Tube0 or Tube2 can be as quick
as one millisecond in duration. The only difference between dual-
and triple-line/stepper perfusion is that dual-line perfusion does
not use Fast1 perfusion or Tube2.
As with single-line perfusion, when designing your experi-
ment you have to determine whether the antagonist is strongly or
weakly bound to the receptor. If the antagonist is strongly bound
and is not displaced during agonist application, then as minimal
set of agonist and antagonist solutions is required to produce a
good concentration–response curve. If the antagonist is weakly
bound and is displaced during agonist application, then a much
larger set of agonist + antagonist solutions is required to get a
good concentration–response curve. For triple-line/stepper perfu-
sion, WinLTP can easily control 16 valves and solutions by Slow0,
Fast1 and Slow1 each, so WinLTP can easily control 16 concen-
trations of antagonist solutions (Slow1) and 32 concentrations of
agonist (+antagonist) solutions (Slow0 and Fast1). The problem is
more cost of the valves and controllers, and the difﬁculty in set-
ting up that many perfusion lines rather than with limitations in
WinLTP.
Fig. 9 shows a protocol involving three perfusion lines and side-
by-side tubes, Tube0, Tube1 and Tube2, controlled by Slow0, Slow1
and Fast1 perfusion, respectively. Fast0 controls a stepper to switch
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Fig. 9. Triple-line automated perfusion with stepper control. The ‘Slow0 Perfuse’, ‘Slow1 Perfuse’ and ‘Fast1 Perfuse’ events in the ‘Protocol Builder’ (upper left) show when
the  Slow0/Tube0, Slow1/Tube1 and Fast1/Tube2 solutions are changed. The upper right panel shows the Slow1/Tube1 switch from Ch1 Antag1 to Ch2 Antag2. The next panel
below  shows the Slow0/Tube0 switch between Ch1 Ag1 and Ch2 Ag2. The next panel below that shows the Fast1/Tube2 switch between Ch1 Ag3 and Ch2 Ag4. The Fast0
Stepper  ‘Continuous Acquisition’ and the Fast0 Stepper ‘P0 Stimulus Sweep Acquisition’ panels show recordings of the AnalogOut1 voltage momentarily changing from Ch1
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rom Tube1 to Tube0, or Tube1 to Tube2. The ‘Slow0 Perfuse’, ‘Slow1
erfuse’ and ‘Fast1 Perfuse’ events in the Protocol Builder (upper
eft) show when the Slow0/Tube0, Slow1/Tube1 and Fast1/Tube2
olutions are changed.
The MainProtocol starts out with the Slow1 Perfuse event mak-
ng sure the Slow1/Tube1 controller is switched to ‘Antag1’. The
low0 Perfuse event makes sure the Slow0/Tube0 controller is
witched to ‘Ag1’, and then switches to ‘Ag2’. The Fast0/Stepper
omentarily switches from ‘Ch1 Tube1’ to ‘Ch0 Tube0’ twice to
omentarily switch from ‘Antag1’ to ‘Ag1’ and then from ‘Antag1’
o ‘Ag2’ as shown in the Fast0 Stepper Continuous Acquisition
anel. The Fast1 Perfuse event makes sure the Fast1/Tube2 con-
roller is switched to ‘Ag3’, and then switches to ‘Ag4’. Then the
ast0/Stepper momentarily switches from ‘Ch1 Tube1’ to ‘Ch2
ube2’ twice to momentarily switch from ‘Antag1’ to ‘Ag3’ and
hen from ‘Antag1’ to ‘Ag4’. Then the Slow1 Perfuse event switches
o ‘Antag2’ and then ‘Ag1’, ‘Ag2’, ‘Ag3’ and ‘Ag4’ were similarly
elivered in ‘Antag2’ as shown in the right side of the Continuous
cquisition panel.ange of AnalogOut1 (‘IC1’) voltage output during a P1sweep from 1 V or Ch1 Tube1
tween sweeps, e.g. Ch1 Tube1. (For interpretation of the references to color in this
4.  Discussion
The addition of automated perfusion change to the automated
stimulation and acquisition provided in the Protocol Builder in
WinLTP goes a substantial way toward enabling fully automated
experiments. The automated perfusion of slice experiments sub-
stantially decreases the difﬁculty of running a single slice/single
chamber experiment. Furthermore, because many WinLTP pro-
grams can be run simultaneously on one computer, and because the
cost of National Instruments boards and WinLTP Advanced Mode
software is low, it becomes feasible to run many independent sin-
gle slice/single chamber experiments simultaneously. Automated
perfusion that includes perfusion changes between sweeps also aids
in the ease of running single cell patch clamp experiments.
Because HEPES or similar buffer is used for single cell
patch-clamp experiments, there are no additional problems with
delivering solutions using the single-line, or the dual- or triple-
line/stepper automated perfusion. However, mammalian brain
slices are usually bathed in warmed bicarbonate buffered solutions
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hat must be bubbled with 95% O2/5% CO2 to maintain the cor-
ect oxygen and pH levels. This means that stale solution in the
erfusion line between the reservoir and the manifold will be deliv-
red when the perfusion is changed to a new solution. Some, and
aybe most, of this stale solution can be removed by pre-ﬂushing
he line between the reservoir and a ‘T’ junction above the valve
o the chamber using either a two valve pre-ﬂush system such as
he Automate AutoPrime system, or a continuous-ﬂow-to-waste
ne valve system. Or the reservoir can be placed directly above the
alve. However, the approximate 9 cm of tubing of approximately
.05 ml  between the ‘T’ junction and the manifold will still contain
tale solution. The effect of this stale solution can be further mini-
ized but not eliminated by using smaller diameter tubing, using
s short a length of tubing between the junction and manifold, using
 larger volume chamber, increasing the ﬂow rate, and using Teﬂon
ubing.
There are several commercial multi-slice systems available
Dunlop et al., 2008). The SynchroSlice from Lohmann Research
www.lohres.com) performs conventional extracellular microelec-
rode recording for a 4 slice/4 chamber, or 8 slice/8 chamber system.
urthermore, its SynchroBrain software is the only multi-slice soft-
are, other than WinLTP, that integrates direct control automated
erfusion into the program stimulation. The Scientiﬁca SliceMaster
www.scientiﬁca.uk.com) is a four slice/4 chamber, or eight slice/8
hamber system that uses conventional extracellular microelec-
rode recording. It can be used with either Cambridge Electronic
esign Spike2 based software (Stopps et al., 2004) or Notocord
ased software (Kroker et al., 2011). The Notocord software does
ot directly control automated perfusion, but instead uses a Scien-
iﬁca program that runs in parallel and that directly controls when
nd what automated perfusion changes take place. The Spike2 soft-
are does not control automated perfusion. MultiChannel Systems
as developed a system, USB-MEA32-STIM4, that can record from
rain slices using a planar 32 channel multi-electrode array system,
nd their LTP-Director software performs LTP experimental pro-
ocols and analyses. Several of these systems could be employed
ogether to produce a similarly priced multi-slice system. The LTP
irector software does not control automated perfusion.
For the single cell patch-clamp experiments, most electrophys-
ological software enables changes to perfusion systems during the
weep by changing analog or digital output during the sweep. In
ddition to WinLTP, there are, to our knowledge, two  patch clamp
lectrophysiological programs that enable changes between as
ell as during sweeps—Heka’s PatchMaster and Molecular Device’s
Clamp. PatchMaster has a Protocol Editor that works similarly to
inLTP’s Protocol Builder. Perfusion changes are made by insert-
ng ‘Set DAC’ and ‘Set Digital Word’ events into the Protocol Editor
cript, which directly control the perfusion controllers between
weeps by changing an analog voltage or a 16-bit digital word.
Clamp uses a Sequence Key List to set the correct analog or digital
utput to change perfusion solutions between sweeps.
In contrast, automated perfusion is fully integrated into the
inLTP program. Perfusion changes between sweeps are made
n WinLTP by inserting a Perfuse event into the Protocol Builder
cript and setting the correct perfusion channel number. WinLTP
lso prints the associated solution label in the Perfuse event, and
utomatically converts the channel number to the correct analog
oltage or digital output. This allows easy control of perfusion con-
rollers, especially when using 4-bit binary digital output, or two
nalog outputs. This perfusion change information is also printednce Methods 207 (2012) 148– 160
to the Experimental Log. These capabilities make it more obvious
when and to what the solution is being changed to. Furthermore,
the perfusion changes are clearly linked in time with the neural
stimulation, which is not the case if the stimulation/acquisition
program is running parallel with a separate perfusion program. And
ﬁnally, WinLTP is the only electrophysiology program that supports
pre-ﬂushing for slice experiments.
There is one additional perfusion system which is useful when
there is a minimal amount of solution—recirculating the waste from
the slice chamber back to the original reservoir. WinLTP can imple-
ment this by using one Perfuse event (e.g. Slow0) to control which
solution to perfuse, and a second Perfuse event (e.g. Slow1) to con-
trol whether the chamber waste solution is recirculated back to the
original reservoir, or is sent to the waste container.
Although the addition of automated perfusion in the Protocol
Builder goes a long way  toward fully automated experiments, there
are several limitations in WinLTP that bar the complete implemen-
tation of this. First, for extracellularly recorded slice experiments,
there is currently no increment/decrement capability for changing
extracellular stimulus amplitude when using a voltage-controlled
stimulus isolator, and so there is no way of running an auto-
mated input–output curve. Second, there is no automated way
of determining when a stable baseline is achieved so that the
rest of the experiment can be run. Instead, the researcher must
unclick the initial continuous loop to run the rest of the experiment.
Third, choosing the correct stimulus amplitude still has to be done
manually. However, running the input–output curve, determining
the correct stimulus amplitude, and determining when a stable
baseline is achieved, are normally performed at the beginning of
the experiment, at least for LTP and similar synaptic plasticity
experiments. This allows most of this type of experiment to be
automated. For patch-clamping experiments, the absence of incre-
ment/decrement intracellular stimulation capability is a similar
drawback. Addition of increment/decrement stimulation and auto-
mated detection of stable baselines are planned in future versions
of WinLTP, although there are no plans to automate determination
of the correct stimulus amplitude.
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